Form 4: Staar Surgical CEO Reports Stock Transaction
Insider Transaction (Form 4)
Warren Foust, President and CEO of Staar Surgical Co, reported multiple transactions in common stock on July 31, 2026.
Summary
- Option exercise/conversion: acquired 20,787 Common Stock on July 31, 2026; holds 97,132 after (Direct).
- Tax/exercise-price withholding: disposed of 10,576 Common Stock at $24.36 ($257,631) on July 31, 2026; holds 86,556 after (Direct).
- Option exercise/conversion: disposed of 20,787 Restricted Stock Units on July 31, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Warren Foust — Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Option exercise/conversion | Common Stock | 20,787 | — | — | 97,132 |
| 2026-07-31 | Tax/exercise-price withholding | Common Stock | 10,576 | $24 | $257.6K | 86,556 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 20,787 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Option exercise/conversion (20,787 shares) |
| 2026-07-31 | Tax/exercise-price withholding (10,576 shares) |
| 2026-07-31 | Option exercise/conversion (20,787 shares) |
Keywords
insider transaction, Form 4, STAA, STAAR SURGICAL CO, neutral, Warren Foust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.